News

Site News

Research shows progress toward a genital herpes vaccine

Research shows progress toward a genital herpes vaccine

More than 8,000 women participated in the NIH-funded study, which was conducted in part at UNC. The vaccine was partially effective at preventing herpes simplex virus type 1 (HSV-1), but did not protect women from herpes simplex virus type 2 (HSV-2).

Research shows progress toward a genital herpes vaccine - Read More…

Distinct AIDS viruses found in cerebrospinal fluid of people with HIV dementia

Distinct AIDS viruses found in cerebrospinal fluid of people with HIV dementia

This is the first study to demonstrate active replication of HIV virus in a cell type other than immune T cells and which may help to predict patients at greatest risk for HIV dementia.

Distinct AIDS viruses found in cerebrospinal fluid of people with HIV dementia - Read More…

New study adds further guidance on when to start antiretroviral therapy for HIV

New study adds further guidance on when to start antiretroviral therapy for HIV

A new study led by researchers at the University of North Carolina at Chapel Hill finds that there may be a limit to how early the therapy, known as HAART, should start.

New study adds further guidance on when to start antiretroviral therapy for HIV - Read More…

Center for AIDS Research federal funding extended through 2016

Center for AIDS Research federal funding extended through 2016

The UNC Center for AIDS Research (CFAR) plays an active role in education and outreach, and provides developmental grant awards to support new ideas and new investigators in HIV/AIDS research.

Center for AIDS Research federal funding extended through 2016 - Read More…

As HIV treatment improves, “trial effect” is diminished, new study suggests

As HIV treatment improves, “trial effect” is diminished, new study suggests

July 13, 2011 – A new study by investigators from the University of North Carolina at Chapel Hill School of Medicine has confirmed the existence of a “trial effect” in clinical trials for treatment of HIV and also shows that effect has diminished over time.

As HIV treatment improves, “trial effect” is diminished, new study suggests - Read More…

UNC tapped to lead national effort to find a cure for AIDS

UNC tapped to lead national effort to find a cure for AIDS

July 11, 2011 -- Researchers at the University of North Carolina at Chapel Hill have been awarded a $32 million, five-year federal grant to develop ways to cure people with HIV by purging the virus hiding in the immune systems of patients taking antiretroviral therapy. Tackling this latent virus is considered key to a cure for AIDS.

UNC tapped to lead national effort to find a cure for AIDS - Read More…

Adimora appointed to NIAID Advisory Council

Adimora appointed to NIAID Advisory Council

July 8, 2011 – Adaora Adimora, MD, MPH, professor of medicine in the Division of Infectious Diseases in the Department of Medicine at UNC, has been appointed to the Advisory Council of the National Institute of Allergy and Infectious Diseases.

Adimora appointed to NIAID Advisory Council - Read More…

Acute Hepatitis A evades immune system more effectively than chronic cousin

Acute Hepatitis A evades immune system more effectively than chronic cousin

In comparing data from experiments with Hepatitis A and Hepatitis C, the research team found that Hepatitis A virus, which causes only acute, self-limited disease, is more efficient at inhibiting the host’s interferon response, and that the virus can actually linger in the body for almost a year.

Acute Hepatitis A evades immune system more effectively than chronic cousin - Read More…

UNC researchers earn prestigious Charles C. Shepard Award

UNC researchers earn prestigious Charles C. Shepard Award

UNC researchers have been awarded the prestigious Charles C. Shepard Science Award in the category of Prevention and Control by the Centers for Disease Control and Prevention for their paper titled, “Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.”

UNC researchers earn prestigious Charles C. Shepard Award - Read More…

Preventing the spread of HIV/AIDS with humanized BLT mice

Preventing the spread of HIV/AIDS with humanized BLT mice

A new study from the University of North Carolina at Chapel Hill School of Medicine further validates the use of humanized BLT mice in the fight to block HIV transmission.

Preventing the spread of HIV/AIDS with humanized BLT mice - Read More…

UNC-led international study shows early treatment with antiretroviral therapy prevents HIV transmission

UNC-led international study shows early treatment with antiretroviral therapy prevents HIV transmission

A research study led by the University of North Carolina at Chapel Hill has made a major discovery in the effort to halt the spread of HIV, the virus that causes AIDS.

UNC-led international study shows early treatment with antiretroviral therapy prevents HIV transmission - Read More…

New public-private partnership will improve health care delivery at more than 130 clinics in Malawi

New public-private partnership will improve health care delivery at more than 130 clinics in Malawi

The USAID-funded Lilongwe Relief Fund Trust of Malawi (LMRFT), in collaboration with the University of North Carolina (UNC) at Chapel Hill and several other public and private partners, has begun implementing the Safeguard the Family Project, which is aimed at decreasing mother-to-child transmission of HIV and reducing maternal and infant mortality.

New public-private partnership will improve health care delivery at more than 130 clinics in Malawi - Read More…

UNC faculty, trainees presented in record numbers at CROI 2011

UNC faculty, trainees presented in record numbers at CROI 2011

The 18th Annual Conference on Retroviruses and Opportunistic Infections (CROI) wrapped up in Boston, Massachusetts, earlier this month, and UNC had a strong presence at this year’s conference.

UNC faculty, trainees presented in record numbers at CROI 2011 - Read More…

School of Medicine uses mobile health clinic to serve hard-to-reach populations, improve research

School of Medicine uses mobile health clinic to serve hard-to-reach populations, improve research

The University of North Carolina at Chapel Hill School of Medicine has launched a new program which will expand both the research and clinical capabilities of the University.

School of Medicine uses mobile health clinic to serve hard-to-reach populations, improve research - Read More…

UNC researchers Jeff Dangl, PhD, and P. Frederick Sparling, MD, have been named fellows of the American Academy of Microbiology

UNC researchers Jeff Dangl, PhD, and P. Frederick Sparling, MD, have been named fellows of the American Academy of Microbiology

Fellows are elected in recognition of excellence, originality and creativity in the microbiological sciences, and have built exemplary careers in basic and applied research, teaching, clinical and public health, industry or government service.

UNC researchers Jeff Dangl, PhD, and P. Frederick Sparling, MD, have been named fellows of the American Academy of Microbiology - Read More…

UNC infectious diseases fellow receives career development award to investigate dengue virus

UNC infectious diseases fellow receives career development award to investigate dengue virus

William Messer, MD, PhD has been awarded a career development award from the Southeast Regional Center of Excellence for Emerging Infections & Biodefense (SERCEB). Messer is a third-year infectious diseases fellow in the Division of Infectious Diseases at the UNC School of Medicine.

UNC infectious diseases fellow receives career development award to investigate dengue virus - Read More…